Besides, we observed higher sensitivity for serum PRM1 to diagnose early-staged CRC (T1-3N0M0), and larger sampled clinical studies as well as well-designed in vivo assays are in want to clarify the tendency of serum PRM1 during tumorigenesis. This evidence concerns the gene PRM1 and colorectal carcinoma.